Venlafaxine 70771-1649-03
- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 1, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA215622
Need to source Venlafaxine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Venlafaxine Hydrochloride | 37.5 mg/1 |
Drug Class
Norepinephrine Uptake Inhibitors [MoA]Serotonin Uptake Inhibitors [MoA]Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
Selected Package
70771-1649-03Selected30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1649-3)
Other packages for this product(2)
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1649-1)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1649-9)